Approval · Notice of Compliance 1395 · 2003
CAMPTOSAR: Notice of Compliance 1395
Issued September 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1395
- Date
- September 11, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMPTOSAR | 02231622 | Cancelled Post Market |
Medicinal ingredients
- IRINOTECAN HYDROCHLORIDE 20 MG per ML